Sema4, an artificial intelligence (AI)-backed genomic and scientific business, final 7 days announced it will exit its reproductive overall health screening organization, resulting in a 448-employee layoff. Its departure from the section is established for the initial quarter of 2023 and, in accordance to a Alert Act Notice submitted in Connecticut, the cuts have an effect on 206 staff members who report to the company’s headquarters in Stamford, 227 who get the job done in the Stamford lab, and 15 from its Branford lab. Following the layoffs, Sema4 now reportedly has about 1,100 staff. These layoff’s appear following the company’s August announcement of a 250-personnel layoff as component of a…